Belzutifan for previously treated advanced renal cell carcinoma [ID6154]
Discontinued
Reference number: GID-TA11086
Please note that following on from a request received from the company, the timelines for this appraisal have been revised and the appraisal is now anticipated to begin in mid- January 2024. These timings are based on a request from the company to reschedule the initial date set by NICE, in order to facilitate a suitably comprehensive and robust submission.